1-3 of 3
Larry J. Suva, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Daratumumab Single Agent and Daratumumab Plus Pomalidomide and Dexametasone in Relapsed/Refractory Multiple Myeloma: A Real Life Retrospective Evaluation

Antonio Branca, MD, Amy Buros, PhD, Donghoon Yoon, PhD, Larry J Suva, PhD, Niels Weinhold, PhD, Leo Rasche, MD, Carolina Schinke, MD, Sharmilan Thanendrarajan, MD, Meera Mohan, MD, Cerisse Harcourt, APRN, OCN, Faith E Davies, MD, Frits van Rhee, MD PhD, Gareth J Morgan, MD PhD, Maurizio Zangari, MD
Journal: Blood
Blood (2016) 128 (22): 4516.
https://doi.org/10.1182/blood.V128.22.4516.4516
Published: 2016
Journal Articles

Heparanase Promotes Myeloma Metastasis By Inducing EMT-like Features in Both Myeloma Cells and Endothelial Cells

Qianying Pan, MD, Patrick D Rowan, BS, Racquel Innis-Shelton, MD, Timothy N Trotter, BS, Mei Li, PhD, Deniz Peker, MD, Larry J Suva, PhD, Yang Yang, MD PhD
Journal: Blood
Blood (2014) 124 (21): 2025.
https://doi.org/10.1182/blood.V124.21.2025.2025
Published: 2014
Journal Articles

Heparanase Promotes the Spontaneous Metastasis of Myeloma Cells to Bone.

Yang Yang, MD, PhD, Veronica MacLeod, MS, Manali Bendre, PhD, Yan Huang, Allison M. Theus, BA, Hua-Quan Miao, PhD, Paul Kussie, PhD, Shmuel Yaccoby, PhD, Joshua Epstein, DSc, Larry J. Suva, PhD, Thomas Kelly, PhD, Ralph D. Sanderson, PhD
Journal: Blood
Blood (2004) 104 (11): 635.
https://doi.org/10.1182/blood.V104.11.635.635
Published: 2004